Managers / Q3 2021 · view latest →
Vident Investment Advisory, LLC
CIK 0001634047 · 1125 SANCTUARY PARKWAY, SUITE 515, ALPHARETTA, GA, 30009 · 404-487-1961
Summary
Vident Investment Advisory, LLC reported $3.3B in U.S.-listed holdings across 1,148 positions for Q3 2021.
Its largest position, AZTA, represents 1.2% of the portfolio.
Compared with Q2 2021, the fund opened 201 new positions and exited 139.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 86.2% · $2.9B
- REIT · 5.1% · $169M
- Other · 4.3% · $142M
- MLP · 2.3% · $75M
- ADR · 1.8% · $61M
- Other · 0.3% · $9M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GXOGXO LOGISTICS INCORPORATED | NEW | +207.2K | 207.2K | +$16M | $16M |
| APPHARVEST INC | NEW | +1.60M | 1.60M | +$10M | $10M |
| SMGSCOTTS MIRACLE-GRO CO | NEW | +36.5K | 36.5K | +$5M | $5M |
| AMYRIS INC | NEW | +348.9K | 348.9K | +$5M | $5M |
| BBWIBATH & BODY WORKS INC | NEW | +73.5K | 73.5K | +$5M | $5M |
| ARENA PHARMACEUTICALS INC | NEW | +71.5K | 71.5K | +$4M | $4M |
| ICLRICON PLC | NEW | +15.9K | 15.9K | +$4M | $4M |
| LPLALPL FINL HLDGS INC | NEW | +21.9K | 21.9K | +$3M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $0 | 1 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.9B | 2,724 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $3.1B | 3,310 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $2.7B | 3,206 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $3.1B | 1,180 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $3.3B | 1,263 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $3.8B | 1,257 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $3.8B | 1,202 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $3.3B | 1,148 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.3B | 1,086 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $3.0B | 987 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.5B | 893 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.0B | 866 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.9B | 1,392 | Jul 28, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2020 | $1.6B | 1,542 | May 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.6B | 976 | Feb 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.1B | 702 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.2B | 685 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.9B | 1,039 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.8B | 1,125 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- O'Shares Investment Advisers, LLC028-19309
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.